Can Hiremiis AU$1.8 Million Placement Support Its Next Phase of Growth?
Source: Kapitales Research
Highlights:
Hiremii Group (ASX: HMI) has secured commitments to raise AU$1.76 million from professional and sophisticated investors.
The capital raising involves the issuance of 42 million newly issued ordinary shares at AU$0.042 per share.
Proceeds will be directed toward platform expansion, AI-driven initiatives, and international growth.
Placement Overview
Hiremii Group has confirmed binding commitments for a placement expected to raise AU$1.76 million before costs. The raising will be completed through the allotment of 42,000,000 fully paid ordinary shares at an issue price of AU$0.042 per share, reflecting pricing set above recent market trading levels.
The placement will be carried out using the company’s existing issuance capacity, enabling the capital raise to be executed efficiently. Settlement is anticipated in late January 2026, after which the new shares will hold the same rights as existing ordinary shares on issue.
Use of Funds and Growth Strategy
Capital raised through the placement will be applied to accelerate the development and scaling of the Hiremii technology platform. Funding will support enhancements to AI-enabled optimisation capabilities, operational expansion, and growth initiatives across Australia, Asia Pacific, and the Americas.
The company also intends to leverage the expertise and networks of incoming investors to strengthen market penetration and assess strategic opportunities aligned with its technology-led recruitment model. A portion of the proceeds will be retained to support near-term working capital requirements as operations continue to scale.
Board Update
In conjunction with the capital raising, Hiremii confirmed that Vaughan Webber will be appointed to the board as a Non-Executive Director and is set to assume the role of Chair from February 2026. The appointment is expected to reinforce governance capability and support the company as it moves into its next stage of execution. Current Chair David Buckingham will transition to a Non-Executive Director role, ensuring continuity at board level.
Outlook
With additional funding secured and refreshed board leadership, Hiremii is positioned to progress its platform expansion and execute on its international growth strategy. Investor focus is likely to remain on delivery against growth initiatives, progress in AI-led optimisation, and the company’s ability to convert scale into sustainable revenue growth.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms & Conditions
Can Hiremiis AU$1.8 Million Placement Support Its Next Phase of Growth?
Highlights:
Placement Overview
Hiremii Group has confirmed binding commitments for a placement expected to raise AU$1.76 million before costs. The raising will be completed through the allotment of 42,000,000 fully paid ordinary shares at an issue price of AU$0.042 per share, reflecting pricing set above recent market trading levels.
The placement will be carried out using the company’s existing issuance capacity, enabling the capital raise to be executed efficiently. Settlement is anticipated in late January 2026, after which the new shares will hold the same rights as existing ordinary shares on issue.
Use of Funds and Growth Strategy
Capital raised through the placement will be applied to accelerate the development and scaling of the Hiremii technology platform. Funding will support enhancements to AI-enabled optimisation capabilities, operational expansion, and growth initiatives across Australia, Asia Pacific, and the Americas.
The company also intends to leverage the expertise and networks of incoming investors to strengthen market penetration and assess strategic opportunities aligned with its technology-led recruitment model. A portion of the proceeds will be retained to support near-term working capital requirements as operations continue to scale.
Board Update
In conjunction with the capital raising, Hiremii confirmed that Vaughan Webber will be appointed to the board as a Non-Executive Director and is set to assume the role of Chair from February 2026. The appointment is expected to reinforce governance capability and support the company as it moves into its next stage of execution. Current Chair David Buckingham will transition to a Non-Executive Director role, ensuring continuity at board level.
Outlook
With additional funding secured and refreshed board leadership, Hiremii is positioned to progress its platform expansion and execute on its international growth strategy. Investor focus is likely to remain on delivery against growth initiatives, progress in AI-led optimisation, and the company’s ability to convert scale into sustainable revenue growth.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au